Rocket Lab (RKLB) Successfully Launches Gen-3 Satellite for AI-Powered Earth Imaging
We recently published a list of Top 10 AI News Wall Street is Paying Attention To. In this article, we are going to take a ...
pharmaphorum23h
HER2 heats up as Seagen licenses RemeGen ADC for $2.6bn
The US company is paying $200 million upfront for rex-Asian rights to RemeGen's disitamab vedotin, with another $2.4 billion in possible future payments tied to future successes across multiple ...